Latest Us Expansion News

Page 3 of 32
Titomic has secured approval for a US$10.3 million direct loan from the US Export-Import Bank to fund a high-pressure cold-spray production cell in Huntsville, Alabama. The project is expected to expand US manufacturing capacity and support at least dozens of full-time jobs.
Victor Sage
Victor Sage
22 Oct 2026
StepChange Holdings delivered a strong start to FY27, with unaudited first-quarter revenue rising 34% to $16.8 million and underlying EBITDA climbing 44% to $1.40 million. The consulting group also expanded its AI Method Library, advanced its US operations and lifted gross margin, although cash declined as acquisition consideration was funded.
Victor Sage
Victor Sage
20 Oct 2026
Pro Medicus has signed a seven-year, A$24 million contract with Billings Clinic - Logan Health for a cloud-based deployment of its Visage 7 imaging platform. The transaction-based structure offers potential additional upside, although the announcement does not quantify future volumes or revenue timing.
Victor Sage
Victor Sage
19 Oct 2026
Adveritas has secured a $2 million placement at a 42.9% premium to its last close, with the proceeds earmarked for product development, marketing and working capital. The funding comes as the company pushes beyond sports betting and gaming while managing delayed Brazilian customer payments.
Sophie Babbage
Sophie Babbage
15 Oct 2026
ARB Corporation’s FY26 profit fell 5.2% as weaker Australian aftermarket and OEM sales outweighed modest export growth. The 4x4 accessories maker is relying on improved vehicle supply, US expansion and new product programs to rebuild momentum in FY27.
Victor Sage
Victor Sage
15 Oct 2026
Bubs Australia delivered 9.2% revenue growth and a sharp underlying EBITDA improvement in FY26, but statutory losses, weaker margins and negative operating cash flow expose the cost of its expansion. Permanent US FDA authorisation removes a major regulatory hurdle, while the annual report still flags material uncertainty around ongoing funding and cash generation.
Victor Sage
Victor Sage
14 Oct 2026
Orthocell says Remplir was placed successfully in five complex robotic prostatectomy cases, with no device-related complications reported over approximately 12 months. The preliminary results will guide a larger prospective trial ahead of a planned US expansion for the nerve repair product.
Ada Torres
Ada Torres
13 Oct 2026
PainChek has expanded its Sabra relationship from two initial facilities to 23 US communities across five operators, covering 808 contracted memory care licences. The immediate test is whether those contracts become implemented recurring revenue by the end of 2026.
Victor Sage
Victor Sage
13 Oct 2026
Nyrada has received supportive written feedback from the US FDA on its proposed pathway for taking Xolatryp into a US Phase IIa heart-attack trial. The regulator identified no major issues, but additional information and stability data are still required before the planned IND submission in the first half of 2027.
Ada Torres
Ada Torres
13 Oct 2026
Ovanti has reported a A$23.61 million FY2026 loss, A$21.27 million in operating cash outflows and only A$291,867 in cash at year end. The ASX-listed fintech has abandoned BNPL globally, but says its continuing operations and proposed funding initiatives provide a basis to keep trading despite a material going-concern uncertainty.
Victor Sage
Victor Sage
6 Oct 2026
IODM has secured the first 15 university commitments in its planned 283-university US rollout, while revenue rose 10.2% despite a sharp fall in UK international student visa applications. The onboarding is not yet revenue, but the December-quarter target gives investors a clear execution test.
Victor Sage
Victor Sage
5 Oct 2026
Artrya has signed a five-year agreement with Huntsville Hospital Health System, converting the first participant in its SAPPHIRE Study into a commercial customer. The deal carries a minimum contracted value of US$0.5 million for Salix Coronary Anatomy, with further usage-based revenue possible from other modules.
Victor Sage
Victor Sage
2 Oct 2026

Browse the archive

Full archive